Open AccessAntibiotics and Adverse Events in Patients with Pancreatic Cancer Treated with Gemcitabine: Looking for Novel Clinical and Preclinical Insights
Author(s) -
El Hassouni Btissame,
Gregori Alessandro,
Puik Jisce R.,
Deng Dongmei,
Kazemier Geert,
Giovannetti Elisa
Publication year - 2021
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1002/onco.13606
Subject(s) - medicine , gemcitabine , adverse effect , pancreatic cancer , antibiotics , intensive care medicine , oncology , cancer , microbiology and biotechnology , biology
This letter to the editor remarks on a recently published article reporting on gemcitabine‐related adverse events associated with antibacterial use, focusing on key points for further consideration.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom